Summary#
This bill adds fentanyl, fentanyl analogues, and certain “counterfeit” fentanyl or methamphetamine products to the list of substances covered by a federal prohibition on specific acts. It also tells the Drug Enforcement Administration (DEA) to make an operation and response plan within 180 days and requires annual reports to Congress about seizures, prosecutions, and prevention efforts.
- Main change: Expands a federal prohibition to explicitly cover fentanyl, fentanyl analogues, and “counterfeit fentanyl or methamphetamine substances” (the bill defines a counterfeit substance as one that contains fentanyl/analogue/methamphetamine and is marketed or sold using another product’s trademark, imprint, or similar mark).
- DEA plan: DEA must make and start an operation and response plan within 180 days that covers enforcement strategies, education and prevention (including tailoring to youth), and an audit of current public campaigns.
- Annual reporting: The Attorney General, with DEA and the Office of National Drug Control Policy, must send Congress an annual report (first due within 1 year) with data on seizures, pill-form breakdowns, substances found, locations and times of seizures, charges, convictions and sentences, and prevention measures.
- Exceptions for sensitive data: The reporting rules allow withholding data that would unseal indictments or harm ongoing investigations.
What it means for you#
- People who make, sell, or distribute counterfeit pills: The bill expands the kinds of pills and counterfeit products that federal law targets. This could increase the chance of federal investigation and seizure for those products.
- Law enforcement and federal agencies: DEA, the Department of Justice (DOJ), and the Office of National Drug Control Policy must create new plans, perform an audit of campaigns, and collect and report detailed annual data. Agencies will have new tasks and deadlines.
- Youth, parents, and schools: The bill requires education and prevention efforts to be increased and tailored to youth and teens. Campaigns like “One Pill Can Kill” are specifically named for review and improvement.
- General public: Congress will receive more regular, detailed data about counterfeit fentanyl/methamphetamine pills and related enforcement. This could affect public awareness campaigns and local outreach efforts.
- Congress: Will receive annual data and analysis that could inform future policy or funding decisions.
Expenses#
No publicly available information.
- The bill does not include a fiscal note or budget estimate in the provided material.
- This would likely require additional staff time and data collection work for DEA, DOJ, and ONDCP. That could mean increased administrative costs for those agencies.
- There may be costs to run or improve public education campaigns and to audit existing campaigns. The bill does not specify funding sources.
Proponents' View#
- The bill appears intended to stop deaths and harms caused by pills that contain fentanyl, fentanyl analogues, or methamphetamine but are made to look like other products.
- It appears intended to strengthen federal ability to investigate and seize counterfeit deadly drugs.
- The bill appears intended to improve prevention and education, with special focus on youth and teens.
- The bill would create regular reporting to give Congress clearer data on where counterfeit pills are seized, what they contain, and how prosecutions proceed.
- Supporters may see the audit of current campaigns as a way to make public awareness work better.
Opponents' View#
- One concern is cost and resources: the bill requires new plans, audits, and annual reports but does not provide funding details. It is unclear how agencies will pay for added work.
- The bill does not clearly explain how the expanded prohibition will differ in practice from existing law. It may be unclear how enforcement or charging decisions will change.
- One concern is about data collection and privacy: the report asks for detailed seizure and prosecution data. Although the bill allows withholding data that would unseal indictments or harm investigations, it is unclear how agencies will balance transparency and confidentiality.
- It is unclear how “tailoring” education to youth will be defined, evaluated, or measured.
- The bill may overlap with existing campaigns and efforts. It does not say how the audit will avoid duplicating work or how findings will be acted on.